Pathway Determination Assay
Metabolic evaluation in the early stage of drug development and lead optimization has become increasingly important. Learning how a compound is eliminated in the human body is quite useful to assess the potential of drug-drug interactions. Pathway determination assay provides critical information regarding the metabolized fraction of drug candidates, which help researchers understand the mechanisms of drug metabolism.
Our scientific team has decades of experience to offer whole in vitro metabolism assay packages for new compounds. We have state-of-the-art instrument and detailed lab services.

Pathway Determination Assay Protocol
| Test system | Human liver microsomes; recombinant human CYPs; recombinant human UGTs |
| Test Compound Concentration | 3 µM (or custom) |
| Time Points | 0, 5, 15, 30, 45, 60 minutes |
| Number of Replicates | 3 |
| Readout | Proposed metabolic pathway metabolite abundance |
| Compound Requirements | 500 µL of 10 mM solution |
| Analysis Method | LC-MS/MS or LC-UV |
| Data Delivery | Remaining of parent and amount of metabolite formation, Half life, Standard error of half life |
Creative Bioarray is dedicated to providing comprehensive services with high effectivity and reliability to accelerate drug development. If you have any special needs or questions regarding our services, please feel free to contact us. We look forward to cooperating with you in the future.
Explore Other Options
For research use only. Not for any other purpose.
Services
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
Molecular Biology Solutions
- Chromosome & Genomic Analysis
-
Cytogenetics & Molecular Cytogenetics Analysis
- Fluorescent In Situ Hybridization (FISH)
- In Situ Hybridization (ISH) & RNAscope
- ImmunoFISH (FISH+IHC)
- I-FISH
- Splice Variant Analysis (FISH)
- RNA FISH in Plant
- mtRNA Analysis (FISH)
- Digital ISH Image Quantification and Statistical Analysis
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- Droplet Digital PCR (ddPCR)
- QuantiGene Plex Assay
- Probe Development & Quality Control
- ISH/FISH Analysis for Therapeutic R&D
- Cell Line Characterization
- Pathogen & Microbial Analysis
- Histology Services
- Exosome Research Services
- Drug Metabolism and Pharmacokinetics (DMPK)
-
Safety Evaluation Services
- High-Throughput Toxicity Screening
- High-Content Cytotoxicity Screening
- In Vitro Cardiotoxicity
- In Vitro Genotoxicity
- In Vitro Hepatotoxicity
- In Vitro Neurotoxicity
- In Vitro Nephrotoxicity
- In Vitro Dermal Toxicology
- Ocular Toxicity
- In Vitro Cytotoxicity
- Endocrine Disruption Screening Assay
- In Vivo Toxicity Study